世界の凍結乾燥製剤再構成用SWFI市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)

GlobalInfoResearchが発行した調査報告書(GIR21JY00001)
◆英語タイトル:Global SWFI for Reconstitution of Lyophilized Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21JY00001
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年7月(※2024年版があります。お問い合わせください。)
◆ページ数:95
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

GlobalInfoResearch社の本調査レポートでは、凍結乾燥製剤再構成用SWFIの世界市場を広く調査・分析し、今後の市場展望をまとめております。凍結乾燥製剤再構成用SWFIの種類別市場規模(バイアル&アンプル、プレフィルドシリンジ)、用途別市場規模(ワクチン、生物製剤、バイオ医薬品)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Baxter、Hospira (ICU Medical)、Vetter、Otsuka、ROVI、Fresenius Kabi、Shijiazhuang No. 4 Pharmaceutical、Hikma、Kelun、Deo Gratias Parenteral
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:バイアル&アンプル、プレフィルドシリンジ
・用途別分析2016年-2026年:ワクチン、生物製剤、バイオ医薬品
・凍結乾燥製剤再構成用SWFIの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・凍結乾燥製剤再構成用SWFIのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・凍結乾燥製剤再構成用SWFIのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・凍結乾燥製剤再構成用SWFIの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・凍結乾燥製剤再構成用SWFIの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The SWFI for Reconstitution of Lyophilized Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global SWFI for Reconstitution of Lyophilized Drugs size is estimated to be xx million in 2021 from USD 12 million in 2020, with a change of XX% between 2020 and 2021. The global SWFI for Reconstitution of Lyophilized Drugs market size is expected to grow at a CAGR of 5.1% for the next five years.

Market segmentation
SWFI for Reconstitution of Lyophilized Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Vials and Ampoules
Pre-Filled Syringes

Market segment by Application can be divided into
Vaccine
Biological Products
Bio-Pharmaceutical

The key market players for global SWFI for Reconstitution of Lyophilized Drugs market are listed below:
Baxter
Hospira (ICU Medical)
Vetter
Otsuka
ROVI
Fresenius Kabi
Shijiazhuang No. 4 Pharmaceutical
Hikma
Kelun
Deo Gratias Parenteral

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe SWFI for Reconstitution of Lyophilized Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of SWFI for Reconstitution of Lyophilized Drugs, with price, sales, revenue and global market share of SWFI for Reconstitution of Lyophilized Drugs from 2019 to 2021.
Chapter 3, the SWFI for Reconstitution of Lyophilized Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the SWFI for Reconstitution of Lyophilized Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and SWFI for Reconstitution of Lyophilized Drugs market forecast, by regions, container and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe SWFI for Reconstitution of Lyophilized Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 SWFI for Reconstitution of Lyophilized Drugs Introduction
1.2 Market Analysis by Container
1.2.1 Overview: Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Vials and Ampoules
1.2.3 Pre-Filled Syringes
1.3 Market Analysis by Application
1.3.1 Overview: Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Vaccine
1.3.3 Biological Products
1.3.4 Bio-Pharmaceutical
1.4 Global SWFI for Reconstitution of Lyophilized Drugs Market Size & Forecast
1.4.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales in Value (2016-2026))
1.4.2 Global SWFI for Reconstitution of Lyophilized Drugs Sales in Volume (2016-2026)
1.4.3 Global SWFI for Reconstitution of Lyophilized Drugs Price by Type (2016-2026) & (US$/Unit)
1.5 Global SWFI for Reconstitution of Lyophilized Drugs Production Capacity Analysis
1.5.1 Global SWFI for Reconstitution of Lyophilized Drugs Total Production Capacity (2016-2026)
1.5.2 Global SWFI for Reconstitution of Lyophilized Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 SWFI for Reconstitution of Lyophilized Drugs Market Drivers
1.6.2 SWFI for Reconstitution of Lyophilized Drugs Market Restraints
1.6.3 SWFI for Reconstitution of Lyophilized Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.1.4 Baxter SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Hospira (ICU Medical)
2.2.1 Hospira (ICU Medical) Details
2.2.2 Hospira (ICU Medical) Major Business
2.2.3 Hospira (ICU Medical) SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.2.4 Hospira (ICU Medical) SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Vetter
2.3.1 Vetter Details
2.3.2 Vetter Major Business
2.3.3 Vetter SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.3.4 Vetter SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Otsuka
2.4.1 Otsuka Details
2.4.2 Otsuka Major Business
2.4.3 Otsuka SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.4.4 Otsuka SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 ROVI
2.5.1 ROVI Details
2.5.2 ROVI Major Business
2.5.3 ROVI SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.5.4 ROVI SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Fresenius Kabi
2.6.1 Fresenius Kabi Details
2.6.2 Fresenius Kabi Major Business
2.6.3 Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.6.4 Fresenius Kabi SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Shijiazhuang No. 4 Pharmaceutical
2.7.1 Shijiazhuang No. 4 Pharmaceutical Details
2.7.2 Shijiazhuang No. 4 Pharmaceutical Major Business
2.7.3 Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.7.4 Shijiazhuang No. 4 Pharmaceutical SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Hikma
2.8.1 Hikma Details
2.8.2 Hikma Major Business
2.8.3 Hikma SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.8.4 Hikma SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Kelun
2.9.1 Kelun Details
2.9.2 Kelun Major Business
2.9.3 Kelun SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.9.4 Kelun SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Deo Gratias Parenteral
2.10.1 Deo Gratias Parenteral Details
2.10.2 Deo Gratias Parenteral Major Business
2.10.3 Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Product and Services
2.10.4 Deo Gratias Parenteral SWFI for Reconstitution of Lyophilized Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 SWFI for Reconstitution of Lyophilized Drugs Sales by Manufacturer
3.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in SWFI for Reconstitution of Lyophilized Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 SWFI for Reconstitution of Lyophilized Drugs Manufacturer Market Share
3.4.2 Top 6 SWFI for Reconstitution of Lyophilized Drugs Manufacturer Market Share
3.5 Global SWFI for Reconstitution of Lyophilized Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and SWFI for Reconstitution of Lyophilized Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global SWFI for Reconstitution of Lyophilized Drugs Market Size by Region
4.1.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2016-2026)
4.2 North America SWFI for Reconstitution of Lyophilized Drugs Revenue (2016-2026)
4.3 Europe SWFI for Reconstitution of Lyophilized Drugs Revenue (2016-2026)
4.4 Asia-Pacific SWFI for Reconstitution of Lyophilized Drugs Revenue (2016-2026)
4.5 South America SWFI for Reconstitution of Lyophilized Drugs Revenue (2016-2026)
4.6 Middle East and Africa SWFI for Reconstitution of Lyophilized Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Type (2016-2026)
5.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Type (2016-2026)
5.3 Global SWFI for Reconstitution of Lyophilized Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Application (2016-2026)
6.2 Global SWFI for Reconstitution of Lyophilized Drugs Revenue by Application (2016-2026)
6.3 Global SWFI for Reconstitution of Lyophilized Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America SWFI for Reconstitution of Lyophilized Drugs Sales by Type (2016-2026)
7.2 North America SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2026)
7.3 North America SWFI for Reconstitution of Lyophilized Drugs Market Size by Country
7.3.1 North America SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Type (2016-2026)
8.2 Europe SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2026)
8.3 Europe SWFI for Reconstitution of Lyophilized Drugs Market Size by Country
8.3.1 Europe SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific SWFI for Reconstitution of Lyophilized Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific SWFI for Reconstitution of Lyophilized Drugs Market Size by Region
9.3.1 Asia-Pacific SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific SWFI for Reconstitution of Lyophilized Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America SWFI for Reconstitution of Lyophilized Drugs Sales by Type (2016-2026)
10.2 South America SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2026)
10.3 South America SWFI for Reconstitution of Lyophilized Drugs Market Size by Country
10.3.1 South America SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Market Size by Country
11.3.1 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa SWFI for Reconstitution of Lyophilized Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 SWFI for Reconstitution of Lyophilized Drugs Typical Distributors
12.3 SWFI for Reconstitution of Lyophilized Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

...

【掲載企業】

Baxter、Hospira (ICU Medical)、Vetter、Otsuka、ROVI、Fresenius Kabi、Shijiazhuang No. 4 Pharmaceutical、Hikma、Kelun、Deo Gratias Parenteral

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の凍結乾燥製剤再構成用SWFI市場2021:メーカー別・地域別・種類別・用途別市場予測(~2026)(Global SWFI for Reconstitution of Lyophilized Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。